Aakaar Medical Technologies IPO open date is June 20, 2025 and the IPO will close on June 24, 2025. Aakaar Medical Technologies IPO is a Book Build Issue. The company to raise around ₹27 crores via IPO that comprises fresh issue of ₹27 crores and offer for sale up to [.] equity shares with face value of ₹10 each.

Aakaar Medical Technologies IPO price band is ₹68 to ₹72 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Aakaar Medical Technologies IPO to list on NSE on June 27, 2025. The allotment of Aakaar Medical Technologies IPO date is June 25, 2025.

The company reported revenue of ₹61.76 crores in 2025 against ₹46.27 crore in 2024. The company reported profit of ₹6.04 crores in 2025 against profit of ₹2.87 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

Aakaar Medical Technologies IPO Details

IPO Open Date:June 20, 2025
IPO Close Date:June 24, 2025
Face Value:₹10 Per Equity Share
IPO Price Band:₹68 to ₹72 Per Share
Issue Size:Approx ₹27 Crores
Fresh Issue:Approx ₹27 Crores
Issue Type:Book Build Issue
IPO Listing:NSE SME
Retail Quota:Not more than 35%
QIB Quota:Not more than 50%
NII Quota:Not more than 15%
DRHP Draft Prospectus:Click Here
RHP Draft Prospectus:Click Here
Anchor Investors List:Click Here

Aakaar Medical Technologies IPO Market Lot

The Aakaar Medical Technologies IPO minimum market lot is 1600 shares with ₹1,15,200 application amount.

ApplicationLot SizeSharesAmount
Retail Minimum11600₹1,15,200
Retail Maximum11600₹1,15,200
S-HNI Minimum23200₹2,30,400

Aakaar Medical Technologies IPO Dates

The Aakaar Medical Technologies IPO date is June 20 and the close date is June 24. The Aakaar Medical Technologies IPO allotment will be finalized on June 25 and the IPO listing on June 27.

IPO Open Date:June 20, 2025
IPO Close Date:June 24, 2025
Basis of Allotment:June 25, 2025
Refunds:June 26, 2025
Credit to Demat Account:June 26, 2025
IPO Listing Date:June 27, 2025

Promoters of Aakaar Medical Technologies IPO

The promoters of the company are Dilip Ramesh Meswani and Bindi Dilip Meswani.

About Aakaar Medical Technologies IPO

Incorporated in 2013, Aakaar Medical Technologies Ltd. is one of the leading medical companies that focuses on providing a wide range of aesthetic and specialized cosmetic products and devices. The company is known to offer specialty products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, and Cosmetologists. The company’s portfolio comprises both its own products and internationally produced devices obtained from various countries such as South Korea, Spain, Italy, and Austria, serving its products and devices to dermatologists, plastic surgeons, and aesthetic physicians, who sell to customers or use them in various treatments. The company’s product range consists of Homecare and professional skin care, Injectable and contouring, Homecare for skin, Professional Hair Care, Professional Skincare products, Hair Growth Serum & Tablets, Medifacial Kit, Device for urinary incontinence, Tattoo removal, pigmentation, and skin rejuvenation devices, Laser Hair Reduction devices and Hair Transplant Device. As of now, the company consists of a team of 90 trained engineers and salespeople. Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu are some of the major states where the company sells its products.

Aakaar Medical Technologies IPO Company Financial Report

The company reported revenue of ₹61.76 crores in 2025 against ₹46.27 crore in 2024. The company reported profit of ₹6.04 crores in 2025 against profit of ₹2.87 crores in 2024.

Amount ₹ in Crores

Period EndedRevenueExpenseProfit After TaxAssets
2023₹32.88₹29.78₹2.15₹23.23
2024₹46.27₹42.39₹2.87₹34.01
2025₹61.76₹53.68₹6.04₹51.85

Aakaar Medical Technologies IPO Valuation – FY2025

Check Aakaar Medical Technologies IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

KPIValues
ROE:33.81%
ROCE:21.02%
EBITDA Margin:15.81%
PAT Margin:9.81%
Debt to equity ratio:0.98
Earning Per Share (EPS):₹6.13 (Basic)
Price/Earning P/E Ratio:11.74
Return on Net Worth (RoNW):33.81%
Net Asset Value (NAV):₹22.26

Show More See the Oswal Pumps IPO RHP for additional information. For the most recent information on the current IPO, future IPOsIPO GMP, today’s IPO GMP, or the IPO Allotment Status, please visit our website at newipo.info. For investors, our trustworthy website provides a number of advantages.